• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.

作者信息

Vergote I

机构信息

Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Eur J Cancer. 2002 Nov;38 Suppl 6:S57-8. doi: 10.1016/s0959-8049(02)00287-3.

DOI:10.1016/s0959-8049(02)00287-3
PMID:12409076
Abstract
摘要

相似文献

1
Fulvestrant versus anastrozole as second-line treatment of advanced breast cancer in postmenopausal women.氟维司群对比阿那曲唑作为绝经后女性晚期乳腺癌二线治疗的疗效
Eur J Cancer. 2002 Nov;38 Suppl 6:S57-8. doi: 10.1016/s0959-8049(02)00287-3.
2
Fulvestrant 250 mg versus anastrozole 1 mg in the treatment of advanced breast cancer: a meta-analysis of randomized controlled trials.氟维司群250毫克与阿那曲唑1毫克治疗晚期乳腺癌的随机对照试验的荟萃分析
Asian Pac J Cancer Prev. 2014;15(5):2095-100. doi: 10.7314/apjcp.2014.15.5.2095.
3
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study.氟维司群 500 mg 对比阿那曲唑 1 mg 作为晚期乳腺癌一线治疗：来自随机 'FIRST' 研究的随访分析。
Breast Cancer Res Treat. 2012 Nov;136(2):503-11. doi: 10.1007/s10549-012-2192-4. Epub 2012 Oct 13.
4
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.氟维司群与阿那曲唑治疗绝经后妇女晚期乳腺癌的疗效比较：两项多中心试验的前瞻性联合分析
Cancer. 2003 Jul 15;98(2):229-38. doi: 10.1002/cncr.11468.
5
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.氟维司群联合阿那曲唑或安慰剂对比依西美坦单药治疗用于绝经后激素受体阳性局部晚期或转移性乳腺癌患者在非甾体芳香化酶抑制剂进展后的 SOFEA 研究：一项综合的、多中心、III 期随机试验。
Lancet Oncol. 2013 Sep;14(10):989-98. doi: 10.1016/S1470-2045(13)70322-X. Epub 2013 Jul 29.
6
Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study.氟维司群500毫克与阿那曲唑1毫克用于晚期乳腺癌一线治疗的比较：II期FIRST研究的总生存分析
J Clin Oncol. 2015 Nov 10;33(32):3781-7. doi: 10.1200/JCO.2015.61.5831. Epub 2015 Sep 14.
7
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.双盲、随机试验：比较氟维司群与阿那曲唑对既往内分泌治疗后病情进展的绝经后晚期乳腺癌女性患者的疗效和耐受性——一项北美试验的结果
J Clin Oncol. 2002 Aug 15;20(16):3386-95. doi: 10.1200/JCO.2002.10.058.
8
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.氟维司群 250mg 对比阿那曲唑治疗中国晚期乳腺癌患者的多中心、双盲、随机 III 期临床研究结果。
Cancer Chemother Pharmacol. 2011 Jan;67(1):223-30. doi: 10.1007/s00280-010-1483-x. Epub 2010 Oct 12.
9
Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.氟维司群（曾用名ICI 182,780）在先前内分泌治疗后病情进展的绝经后晚期乳腺癌女性患者中，其疗效与阿那曲唑相当。
J Clin Oncol. 2002 Aug 15;20(16):3396-403. doi: 10.1200/JCO.2002.10.057.
10
Combination anastrozole and fulvestrant in metastatic breast cancer.阿那曲唑与氟维司群联合治疗转移性乳腺癌。
N Engl J Med. 2012 Aug 2;367(5):435-44. doi: 10.1056/NEJMoa1201622.

引用本文的文献

1
From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target.从雌激素受体的纯拮抗剂到纯降解剂：针对同一靶点的不断演进的策略。
ACS Omega. 2021 Mar 30;6(14):9334-9343. doi: 10.1021/acsomega.0c06362. eCollection 2021 Apr 13.
2
Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer.戈舍瑞林与依西美坦联合治疗绝经前局部晚期或转移性乳腺癌的II期试验。
Medicine (Baltimore). 2015 Jul;94(26):e1006. doi: 10.1097/MD.0000000000001006.
3
Breast cancer management in the elderly.
老年乳腺癌的管理。
Clin Transl Oncol. 2014 Apr;16(4):351-61. doi: 10.1007/s12094-013-1113-2. Epub 2013 Oct 2.
4
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.用于治疗绝经后女性晚期乳腺癌的芳香化酶抑制剂
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003370. doi: 10.1002/14651858.CD003370.pub3.